First Time Loading...

Theravance Biopharma Inc
NASDAQ:TBPH

Watchlist Manager
Theravance Biopharma Inc Logo
Theravance Biopharma Inc
NASDAQ:TBPH
Watchlist
Price: 9.38 USD -0.95% Market Closed
Updated: May 11, 2024

Theravance Biopharma Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theravance Biopharma Inc
Operating Expenses Peer Comparison

Comparables:

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Theravance Biopharma Inc
NASDAQ:TBPH
Operating Expenses
-$110.7m
CAGR 3-Years
33%
CAGR 5-Years
18%
CAGR 10-Years
3%

See Also

What is Theravance Biopharma Inc's Operating Expenses?
Operating Expenses
-110.7m USD

Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Operating Expenses amounts to -110.7m USD.

What is Theravance Biopharma Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
3%

Over the last year, the Operating Expenses growth was 15%. The average annual Operating Expenses growth rates for Theravance Biopharma Inc have been 33% over the past three years , 18% over the past five years , and 3% over the past ten years .